PRINCETON, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. , a leading provider of identity DNA testing services, today announced that Paul J. Kelly, M.D., president and chief executive officer of Orchid Cellmark, is scheduled to present at the Rodman and Renshaw Techvest 7th Annual Healthcare Conference in New York City on Monday, November 7, 2005 at 12:40 p.m. EST. Dr. Kelly will provide a brief corporate overview and discuss the company's recent progress.
A live and archived webcast of Dr. Kelly's presentation will be available at http://wsw.com/webcast/rrshq7/orch. Alternatively, the live and archived webcast can be accessed via the Investors section of Orchid Cellmark's website at http://www.orchid.com, and will be available for 90 days following the presentation.
About Orchid Cellmark
Orchid Cellmark is a leading provider of identity DNA testing services for the human identity and agriculture markets. In the human identity area, the company provides DNA testing services for forensic, family relationship and security applications. In the agriculture field, Orchid Cellmark provides DNA testing services for selective trait breeding. Orchid Cellmark's strong market positions in these segments reflect the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the world-renowned Cellmark brand that has been associated with exceptional quality, reliability and customer service for nearly two decades. More information on Orchid Cellmark can be found at http://www.orchid.com
Orchid Cellmark Inc.
CONTACT: Tracy J. Henrikson, Executive Director, Corporate Communicationsof Orchid Cellmark, +1-609-750-2221